1 completed, 1 unknown, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
Follow Plegridy: new trials by email Literature Review of Plegridy trials Research Report on Plegridy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects Plegridy, Prednisone, Tylenol Pill - Multiple Sclerosis | Phase 4 | Unknown | Holy Name Medical Center, Inc. | 50 | 2017-09-25 | 2019-08-15 |
| Plegridy Satisfaction Study in Participants peginterferon beta-1a - Relapsing-Remitting Multiple Sclerosis (RRMS) | Phase 4 | Completed | Biogen | 193 | 2016-02-03 | 2023-08-31 |
| Brimonidine Tartrate for the Treatment of Injection Related Erythema peginterferon beta-1a, brimonidine tartrate, Vehicle Gel - Relapsing-Remitting Multiple Sclerosis (RRMS) | Phase 4 | Withdrawn | Biogen | 2016-02-01 | 2016-04-25 |
Injection Site Reaction (2) · Multiple Sclerosis, Relapsing-Remitting (2) · Demyelinating Diseases (1) · Erythema (1) · Multiple Sclerosis (1)
Biogen (2) · Holy Name Medical Center, Inc. (1)
Italy (1) · United States (1)
PMID 15304586, PMID 17588298, PMID 9633761
2015 (2)